AI-guided generation of novel GUCY2C-targeting T-cell engagers for the treatment of colorectal cancer

被引：0
|
作者：
Tian, Liang
Hou, Jinxiu
Su, Chenpeng
Xu, Xiaoou
Chen, Xiaoqian
Liu, Dandan
Tian, Jiyuan
Shen, Rui
Pan, Yi
Yuan, Yuan
Dong, Lisha
Gu, Tingting
Peng, Jian
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6721
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6721
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma
    Pikman, Yana
    Conway, Amy Saur
    Robichaud, Amanda L.
    Kitara, Samuel
    Church, Alanna J.
    Kennedy, Alyssa L.
    Silverman, Lewis B.
    Billett, Amy L.
    Weinstock, David M.
    Harris, Marian H.
    Stegmaier, Kimberly
    BLOOD ADVANCES, 2020, 4 (07) : 1265 - 1269
  • [22] GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
    Magee, Michael S.
    Kraft, Crystal L.
    Abraham, Tara S.
    Baybutt, Trevor R.
    Marszalowicz, Glen P.
    Li, Peng
    Waldman, Scott A.
    Snook, Adam E.
    ONCOIMMUNOLOGY, 2016, 5 (10):
  • [23] Promising real-world data of treatment with two BCMA-targeting bispecific T-cell engagers in extensively pretreated myeloma patients
    Strifler, S.
    Wendelin, K.
    Hefter, C.
    Soldatenko, N.
    Morgenstern, N.
    Illing, S.
    Starke, M.
    Dressler, S.
    Gaertner, J.
    Schaefer-Eckart, K.
    Knop, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 313 - 313
  • [24] Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex
    Wang, Zhongyuan
    Zhou, Liang
    Xiong, Yanpeng
    Yu, Shubin
    Li, Huan
    Fan, Jiaoyang
    Li, Fan
    Su, Zijie
    Song, Jiaxing
    Sun, Qi
    Liu, Shan-Shan
    Xia, Yuqing
    Zhao, Liang
    Li, Shiyue
    Guo, Fang
    Huang, Peng
    Carson, Dennis A.
    Lu, Desheng
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (17) : 3390 - 3406
  • [25] Reprogramming T cell Glycosylation: a novel immunotherapeutic strategy in Colorectal Cancer Treatment
    Azevedo, Catarina M.
    Fernandes, Angela
    Xie, Bingxian
    Henrique, Rui M.
    Dinis-Ribeiro, Mario
    Marcos-Pinto, Ricardo
    Delgoffe, Greg M.
    Pinho, Salome S.
    GLYCOBIOLOGY, 2023, 33 (11) : 1040 - 1041
  • [26] A novel trispecific T cell engager antibody for dual-targeting in colorectal cancer inmunotherapy
    Tapia Galisteo, Antonio
    Sanchez Rodriguez, Inigo
    Iglesias Hernandez, Patricia
    Martin Garcia, Laura
    Compte Grau, Marta
    Navarro Ortiz, Rocio
    Alvarez Vallina, Luis
    Sanz Alcober, Laura
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 394 - 394
  • [27] Novel conditionally active tetravalent B7-H3 x CD3 T-cell engagers targeting solid tumors
    Cugnetti, Ana Paula
    Liu, Haizhen
    McNeeley, Patricia
    Woodard, Kathryn
    Chang, Cathy
    Frey, Gerhard
    Boyle, William J.
    Short, Jay M.
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients
    Snook, Adam E.
    Baybutt, Trevor R.
    Xiang, Bo
    Abraham, Tara S.
    Flickinger, John C., Jr.
    Hyslop, Terry
    Zhan, Tingting
    Kraft, Walter K.
    Sato, Takami
    Waldman, Scott A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [29] Engineering a Novel T-Cell Epitope-Based Vaccine Targeting PRAME in Cancer Immunotherapy
    Bayat, Zeynab
    Majidi, Zahra
    Taherkhani, Amir
    Samie, Lida
    PEPTIDE SCIENCE, 2025, 117 (01):
  • [30] Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
    Magee, Michael S.
    Abraham, Tara S.
    Baybutt, Trevor R.
    Flickinger, John C., Jr.
    Ridge, Natalie A.
    Marszalowicz, Glen P.
    Prajapati, Priyanka
    Hersperger, Adam R.
    Waldman, Scott A.
    Snook, Adam E.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (05) : 509 - 516
12345